TMEM218 is a small protein consisting of 115 amino acids with presently limited characterized function. Despite its small size, this protein demonstrates remarkable evolutionary conservation across species, suggesting its critical biological importance . The protein's structure features transmembrane domains that anchor it within cellular membranes, contributing to its functional role in various tissues.
The gene encoding TMEM218 has been extensively mapped and studied across multiple species. In rats, for instance, the gene has been thoroughly documented in the Rat Genome Database, with associated sequences available in multiple reference databases including RefSeq (NM_001008325) and GenBank (BC085342) . This conservation across species highlights TMEM218's biological significance and suggests fundamental cellular functions that have been preserved throughout evolution.
Expression analysis has revealed that TMEM218 is predominantly found in tissues containing ciliated or flagellated cells. Specifically, the protein shows notable expression in:
Renal epithelial cells
Retinal tissue
Respiratory epithelium
Ependymal and choroid plexus cells
Reproductive tissues (vas deferens, epididymis, and spermatids)
Various endocrine cells including pancreatic islets, pituitary gland, adrenal medulla, parathyroid gland, and thyroid C-cells
This expression pattern strongly correlates with the protein's suspected role in ciliary development and function, which has significant implications for understanding related pathologies.
Research utilizing knockout mouse models (Tmem218−/−) has provided critical insights into the biological function of TMEM218. These studies have demonstrated that TMEM218 deficiency leads to two primary pathological outcomes: progressive cystic kidney disease and retinal degeneration . These findings are particularly significant as they mirror the clinical presentation of Senior-Løken syndrome in humans, suggesting that the Tmem218−/− mouse could serve as a valuable model for this condition.
The kidney pathology in TMEM218-deficient mice is characterized by:
Diffuse renal cyst development
Progressive interstitial fibrosis
Collagen deposition throughout the kidney
Tubular basement membrane disintegration
Tubular atrophy and cyst formation
Concurrently, the retinal pathology includes:
Slowly progressive retinal degeneration
Diffuse thinning of the outer nuclear layer
Degeneration of photoreceptor inner and outer segments
Relatively preserved inner retina with normal inner nuclear and ganglion cell layers
These pathological features strongly suggest that TMEM218 plays a critical role in ciliary biogenesis or function, as many ciliopathies present with similar renal and ocular manifestations.
Recombinant bovine Transmembrane protein 218 (TMEM218) represents a biotechnologically engineered form of the native bovine protein, produced using recombinant DNA technology . The recombinant form enables researchers to study the protein's structure, function, and potential interactions without the limitations associated with extracting the native protein from animal tissues.
Commercial availability of recombinant bovine TMEM218 has facilitated research in this field. Companies such as MyBioSource offer partial recombinant bovine TMEM218 products (such as catalog number MBS7057718) for research applications . Similarly, Creative BioMart lists recombinant TMEM218 proteins from various species, including bovine, produced in different expression systems like mammalian cells, HEK293 cells, and E. coli .
Recombinant bovine TMEM218 is typically produced using one of several expression systems:
| Expression System | Advantages | Limitations | Common Tags |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid production | Limited post-translational modifications | His, Non, Avi |
| Mammalian cells (HEK293) | Proper folding, post-translational modifications | Higher cost, lower yield | His, Fc |
| Insect cells | Higher yield than mammalian, some post-translational modifications | More complex than bacterial systems | His, GST |
The choice of expression system depends on the specific research requirements, particularly whether post-translational modifications are essential for the protein's functionality in experimental conditions.
Recombinant bovine TMEM218 has emerged as a valuable research tool for investigating ciliopathies and related disorders. The protein enables several key research applications:
The association between TMEM218 dysfunction and ciliopathies makes recombinant bovine TMEM218 particularly valuable for developing in vitro model systems. These models can help elucidate the pathogenic mechanisms underlying conditions such as Senior-Løken syndrome, Joubert syndrome, and Meckel syndrome .
Bovine TMEM218 shares significant homology with human TMEM218, making it useful for comparative studies. Researchers can investigate species-specific differences in protein function and apply these insights to human disease mechanisms. The evolutionary conservation of TMEM218 across species supports its use as a model for human protein function .
Research utilizing recombinant TMEM218 has significant clinical implications, particularly in understanding and potentially treating ciliopathies.
TMEM218 dysfunction has been linked to several ciliopathies:
Senior-Løken Syndrome: Characterized by nephronophthisis and retinal degeneration, mirroring the phenotype observed in Tmem218−/− mice .
Joubert Syndrome: A ciliopathy affecting brain development with features including cerebellar vermis hypoplasia and characteristic "molar tooth" appearance on MRI .
Meckel Syndrome: A severe ciliopathy with features including encephalocele, polycystic kidneys, and polydactyly .
The association with these conditions highlights TMEM218's role in ciliary function and its importance in multiple organ systems during development and throughout life.
Understanding TMEM218's function through studies with recombinant proteins could potentially lead to novel therapeutic approaches for ciliopathies. While currently at the research stage, potential interventions might include:
Gene therapy approaches to restore TMEM218 function
Small molecule therapies targeting pathways affected by TMEM218 dysfunction
Cell-based therapies to replace affected tissues
The Tmem218−/− mouse model has proven invaluable for understanding the pathophysiology of TMEM218-related disorders. This model exhibits both renal cysts and retinal degeneration, making it particularly useful for studying Senior-Løken syndrome . The gene-trapped allele (Tmem218Gt(OST40451)Lex) interrupts endogenous transcription within the 5' UTR, preventing proper protein expression.
Experimental data from these models has revealed several key insights:
The disruption of normal TMEM218 expression leads to progressive renal cystic disease resembling nephronophthisis.
Retinal degeneration becomes evident by 14 weeks of age in mouse models, with progressive thinning of the outer nuclear layer.
β-galactosidase enzyme histochemistry in Tmem218−/− mice has identified TMEM218 expression in ciliated and flagellated cells, supporting its role in ciliary function .
These experimental findings provide a foundation for understanding the molecular mechanisms underlying TMEM218-related pathologies and for developing potential therapeutic interventions.
Research on TMEM218 and its recombinant forms continues to evolve, with several promising avenues for future investigation:
Despite significant progress in understanding the consequences of TMEM218 deficiency, its precise molecular function remains incompletely characterized. Future research using recombinant bovine TMEM218 could help elucidate its specific role in ciliary biogenesis and function, potentially revealing new targets for therapeutic intervention.
The Tmem218−/− mouse model provides an opportunity to test novel therapeutic approaches for related ciliopathies. As noted by researchers, "the Tmem218−/− mouse might be used in the development and testing of novel therapeutic approaches to the prevention and treatment of the renal and retinal ciliopathies seen in [Senior-Løken Syndrome]" .
Combining recombinant TMEM218 studies with genomics, proteomics, and metabolomics approaches could provide a more comprehensive understanding of the protein's function in normal development and disease states. This integrated approach might reveal previously unknown interactions and regulatory mechanisms.
Bovine TMEM218 is a multi-pass transmembrane protein predominantly localized to primary cilia and cilia-related compartments. The protein contains multiple transmembrane domains that anchor it within the ciliary membrane. Structurally, it shares high sequence homology with human TMEM218, which functions as part of protein complexes in ciliary compartments. Immunofluorescence studies typically reveal TMEM218 localization patterns consistent with ciliary membrane distribution, often co-localizing with other ciliary markers.
Methodologically, researchers can visualize TMEM218 localization using confocal microscopy with antibodies specific to bovine TMEM218 or via expression of tagged recombinant protein (GFP-TMEM218) in bovine cell lines. When designing localization experiments, it's essential to include appropriate ciliary markers (such as acetylated α-tubulin) for co-localization studies .
While the complete interactome of bovine TMEM218 remains under investigation, research indicates that TMEM218 engages in protein-protein interactions critical for ciliary function. Based on homology with human TMEM218, the bovine variant likely interacts with components of the transition zone complex, including proteins involved in Joubert Syndrome and Meckel-Gruber Syndrome pathways.
Methodologically, researchers can investigate TMEM218 interactions through:
Co-immunoprecipitation assays using anti-TMEM218 antibodies
Proximity ligation assays in bovine cell models
Yeast two-hybrid screening with TMEM218 as bait
BioID or APEX2 proximity labeling approaches
When designing interaction experiments, consider that membrane protein interactions often require specialized conditions to maintain native conformation during extraction .
Bovine TMEM218 shares approximately 85-90% sequence identity with human TMEM218, with highest conservation in the transmembrane domains. Functionally, both proteins are implicated in ciliary biology and appear to participate in similar molecular pathways.
To experimentally compare the two orthologs, researchers typically:
Perform rescue experiments in human cell lines with bovine TMEM218
Create chimeric proteins to identify functionally conserved domains
Conduct comparative interactome studies to identify species-specific binding partners
Analyze post-translational modification patterns between species
These comparative approaches help determine which functional aspects of TMEM218 are evolutionarily conserved versus species-specific .
Multiple expression systems have been utilized for bovine TMEM218 production, each with distinct advantages:
| Expression System | Advantages | Challenges | Typical Yield |
|---|---|---|---|
| E. coli | Rapid growth, low cost, high yield | Potential improper folding, lack of PTMs | 5-10 mg/L |
| Mammalian cells (HEK293) | Native folding, appropriate PTMs | Higher cost, longer production time | 1-5 mg/L |
| Insect cells | Higher yield than mammalian, some PTMs | Medium complexity system | 3-8 mg/L |
For optimal functional studies, mammalian expression systems (particularly HEK293) are preferred as they provide proper folding and post-translational modifications essential for TMEM218 function. For structural studies requiring higher yields, insect cell expression offers a good compromise between yield and proper protein folding.
The choice of purification tags (His, Avi, Fc) should be determined by downstream applications. His tags provide efficient purification but may interfere with certain protein interactions, while Fc-fusion proteins can enhance stability but introduce significant size to the construct .
Purification of functional bovine TMEM218 requires careful optimization to maintain native structure:
Membrane extraction: Use mild detergents such as DDM (n-Dodecyl β-D-maltoside) or LMNG (lauryl maltose neopentyl glycol) at concentrations just above their critical micelle concentration
Buffer composition: Include stabilizing agents (glycerol 10-15%) and appropriate salt concentration (typically 150-300 mM NaCl)
pH range: Optimal activity is typically maintained between pH 7.0-8.0
Temperature: Perform all purification steps at 4°C to minimize protein degradation
A typical purification workflow involves:
Initial IMAC (immobilized metal affinity chromatography) for His-tagged proteins
Size exclusion chromatography to remove aggregates and ensure monodispersity
Optional ion exchange chromatography for increased purity
Critical quality control steps include Western blotting to confirm protein identity, dynamic light scattering to assess monodispersity, and functional assays to verify protein activity post-purification .
TMEM218 has been identified as a causative gene in ciliopathies, particularly Joubert Syndrome and Meckel-Gruber Syndrome. According to the CiliaMiner database, TMEM218 mutations are associated with specific clinical presentations:
For Joubert Syndrome, TMEM218 mutations correlate with:
Ataxia
Coloboma
Cystic kidney dysplasia
Eye anomalies
Respiratory insufficiency
Widely spaced or irregular teeth
For Meckel-Gruber Syndrome, TMEM218 mutations are associated with:
Anencephaly
Cystic kidney dysplasia
Occipital encephalocele
Polydactyly
Renal anomalies
Functionally, TMEM218 appears to work in concert with other ciliary proteins including TCTN3 and TXNDC15 in maintaining ciliary structure and function. Disruption of TMEM218 likely impairs ciliary signaling pathways critical for embryonic development .
TMEM218 functions within a network of ciliary proteins, with disruption of this network contributing to ciliopathy phenotypes. Key interactions include:
Transition zone components: TMEM218 interacts with transition zone proteins that regulate ciliary composition
TCTN complex: TMEM218 associates with the tectonic complex (including TCTN3) that controls ciliary membrane composition
IFT machinery: While not directly part of intraflagellar transport, TMEM218 function affects proper IFT protein localization
In the context of ciliopathies, mutations in TMEM218 potentially disrupt multiple protein interactions, as evidenced by shared disease genes between Joubert Syndrome and Meckel-Gruber Syndrome. The CiliaMiner database identifies several genes that function in overlapping pathways with TMEM218, including CEP290, TCTN3, and TXNDC15.
To experimentally investigate these interactions in disease contexts, researchers typically employ co-immunoprecipitation studies combined with mass spectrometry to identify altered protein interactions in wild-type versus mutant conditions .
Several complementary approaches are recommended for assessing TMEM218 function:
Ciliary morphology analysis:
Immunofluorescence microscopy to measure cilia length, frequency, and morphology
Scanning electron microscopy for detailed ultrastructural analysis
Live imaging with fluorescently tagged TMEM218 to track dynamics
Ciliary signaling assays:
Hedgehog pathway activity measurement using Gli transcription factor translocation
PDGF signaling assessment through receptor localization and downstream phosphorylation events
Calcium imaging to evaluate ciliary calcium signaling
Protein trafficking analysis:
FRAP (Fluorescence Recovery After Photobleaching) to measure protein dynamics
Selective permeabilization assays to distinguish ciliary vs. cytoplasmic protein pools
Super-resolution microscopy to precisely localize TMEM218 within ciliary subdomains
These assays should be performed in appropriate cellular contexts, such as serum-starved cells to induce ciliation, and include both gain-of-function and loss-of-function experimental designs .
Understanding TMEM218 topology and modifications requires specialized approaches:
Membrane topology analysis:
Protease protection assays using selectively permeabilized cells
Glycosylation mapping with N-glycosylation site mutations
SCAM (Substituted Cysteine Accessibility Method) to identify exposed residues
Cryo-EM structural analysis for high-resolution topology determination
Post-translational modification (PTM) mapping:
Mass spectrometry to identify modification sites (phosphorylation, ubiquitination, etc.)
Site-directed mutagenesis of putative modification sites to assess functional consequences
Phospho-specific or ubiquitin-specific antibodies to detect modifications
Pulse-chase experiments to determine modification dynamics
When performing these analyses, it's crucial to consider native cellular contexts, as membrane protein topology and modifications may differ between artificial and physiological environments .
TMEM218 serves as a valuable tool for ciliary proteome investigations through several approaches:
BioID proximity labeling:
Generate TMEM218-BioID fusion proteins to biotinylate proximal proteins
After expression in bovine cells and streptavidin pulldown, identify biotinylated proteins by mass spectrometry
Compare wild-type vs. mutant TMEM218-BioID to identify mutation-specific changes in the local interactome
Comparative ciliary proteomics:
Use TMEM218 knockout or knockdown cells to identify changes in the ciliary proteome
Perform quantitative proteomics on isolated cilia from control vs. TMEM218-deficient cells
Integrate datasets with known ciliary protein databases (such as CiliaMiner) to identify novel components
Temporal interactome analysis:
Utilize inducible TMEM218 expression systems to capture dynamic interactions during ciliogenesis
Implement time-resolved proximity labeling to map changing protein interactions during ciliary assembly and disassembly
These approaches contribute to understanding broader ciliary biology beyond TMEM218's immediate function, potentially identifying novel therapeutic targets for ciliopathies .
Cutting-edge approaches for visualizing TMEM218 dynamics include:
Advanced imaging techniques:
Lattice light-sheet microscopy for extended live imaging with reduced phototoxicity
Single-molecule tracking to follow individual TMEM218 molecules within cilia
FRET-based biosensors to detect TMEM218 conformational changes or interactions
Optogenetic control:
Light-inducible dimerization systems to control TMEM218 interactions
Optogenetic recruitment of TMEM218 to specific ciliary domains
Photoswitchable fluorescent proteins to track specific subpopulations of TMEM218
Correlative light and electron microscopy (CLEM):
Combine live imaging of fluorescently tagged TMEM218 with subsequent electron microscopy
Precisely localize TMEM218 within ciliary ultrastructure at specific timepoints
These techniques enable researchers to move beyond static snapshots of TMEM218 localization and understand its dynamic behavior in functioning cilia. When implementing these approaches, careful optimization of tagging strategies is essential to avoid disrupting native protein function .
Investigating the relationship between TMEM218 mutations and transition zone architecture requires sophisticated experimental approaches:
Structural analysis techniques:
Transmission electron microscopy of ciliary transition zones in TMEM218 mutant cells
Expansion microscopy to visualize transition zone protein organization at enhanced resolution
Cryo-electron tomography to resolve molecular details of transition zone architecture
Functional barrier assays:
Measure ciliary protein diffusion barriers using photoactivatable fluorescent proteins
Assess small molecule permeability into cilia using chemical sensors
Evaluate phosphoinositide distribution between ciliary and plasma membranes
Comparative mutational analysis:
Generate a panel of disease-associated TMEM218 mutations and assess their impact on transition zone structure
Perform rescue experiments with wild-type vs. mutant TMEM218 to identify critical functional domains
Correlate transition zone defects with specific clinical presentations in ciliopathy patients
Research suggests that TMEM218 mutations may disrupt the transition zone's function as a diffusion barrier, potentially explaining the molecular basis of associated ciliopathies. The precise mechanisms vary between mutations, potentially explaining the phenotypic heterogeneity observed in patients with TMEM218-related conditions .
TMEM218 exhibits significant evolutionary conservation across mammalian species, reflecting its fundamental role in ciliary biology:
| Species | Sequence Identity to Human | Conserved Domains | Species-Specific Features |
|---|---|---|---|
| Bovine | ~85-90% | Transmembrane domains, C-terminal region | Minor variations in N-terminal sequence |
| Mouse | ~80-85% | Transmembrane domains, C-terminal region | Longer linker between TM domains 2-3 |
| Rat | ~80-85% | Transmembrane domains, C-terminal region | Similar to mouse variations |
| Zebrafish | ~65-70% | Core transmembrane architecture | More divergent N- and C-termini |
Comparative genomic approaches, including phylogenetic analysis and identification of conserved regulatory elements, provide insights into TMEM218 evolution and potentially identify critical functional regions under evolutionary constraint .
Bovine models offer several advantages for translational ciliopathy research:
Advantages of bovine systems:
Larger cell size facilitating certain imaging approaches
Availability of primary tissues and cells
Similar ciliary architecture to humans
Conserved ciliary signaling pathways
Translational approaches:
Generate bovine cell lines with human patient-specific TMEM218 mutations
Perform cross-species rescue experiments to test functional conservation
Develop organ-on-chip models using bovine cells to study tissue-specific ciliopathy manifestations
Considerations and limitations:
Species-specific differences in development and ciliary function
Variations in genetic background effects
Differences in ciliopathy phenotype penetrance
When designing translational studies, researchers should validate findings across multiple species models, ideally including patient-derived cells when available. The integrated analysis of bovine, mouse, and human data provides the most comprehensive understanding of TMEM218 function in ciliopathies .